Download PDF
J Pediatr Genet 2024; 13(01): 069-079
DOI: 10.1055/s-0041-1736613
Case-Based Review

Osteogenesis Imperfecta and Split Foot Malformation due to 7q21.2q21.3 Deletion Including COL1A2, DLX5/6 Genes: Review of the Literature

Özden Öztürk
1   Department of Medical Genetics, Medical School of Adiyaman University, Adiyaman, Türkiye
,
Haydar Bagis 
1   Department of Medical Genetics, Medical School of Adiyaman University, Adiyaman, Türkiye
,
Semih Bolu 
2   Department of Pediatrics, Division of Pediatric Endocrinology, Medical School of Adiyaman University, Adiyaman, Türkiye
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Copy number variation in loss of 7q21 is a genetic disorder characterized by split hand/foot malformation, hearing loss, developmental delay, myoclonus, dystonia, joint laxity, and psychiatric disorders. Osteogenesis imperfecta caused by whole gene deletions of COL1A2 is a very rare condition. We report a Turkish girl with ectrodactyly, joint laxity, multiple bone fractures, blue sclera, early teeth decay, mild learning disability, and depression. A copy number variant in loss of 4.8 Mb at chromosome 7 (q21.2q21.3) included the 58 genes including DLX5, DLX6, DYNC1I1, SLC25A13, SGCE, and COL1A2. They were identified by chromosomal microarray analysis. We compared the findings in our patients with those previously reported. This case report highlights the importance of using microarray to identify the genetic etiology in patients with ectrodactyly and osteogenesis imperfecta.

Keywords

7q21 deletion - ectrodactyly - osteogenesis imperfecta - split foot malformation - SHFM

Availability of Data and Materials

All data used in this study are available from the corresponding author on reasonable request.


Authors' Contributions

H.B. and Ö.Ö. designed the study; S.B. and Ö.Ö. examined the patient and family; H.B. and Ö.Ö. wrote the manuscript and evaluated the genetic test. All authors read and approved the final manuscript.




Publication History

Received: 11 April 2021

Accepted: 22 September 2021

Article published online:
02 November 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Asmus F, Hjermind LE, Dupont E. et al. Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype. Brain 2007; 130 (Pt 10): 2736-2745
    Google Scholar
  • 2 Tayebi N, Jamsheer A, Flöttmann R. et al. Deletions of exons with regulatory activity at the DYNC1I1 locus are associated with split-hand/split-foot malformation: array CGH screening of 134 unrelated families. Orphanet J Rare Dis 2014; 9 (01) 108
    Google Scholar
  • 3 Byers PH, Steiner RD. Osteogenesis imperfecta. Annu Rev Med 1992; 43 (01) 269-282
    Google Scholar
  • 4 Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A 2014; 164A (06) 1470-1481
    Google Scholar
  • 5 Bonafe L, Cormier-Daire V, Hall C. et al. Nosology and classification of genetic skeletal disorders: 2015 revision. Am J Med Genet A 2015; 167A (12) 2869-2892
    Google Scholar
  • 6 van Silfhout AT, van den Akker PC, Dijkhuizen T. et al. Split hand/foot malformation due to chromosome 7q aberrations(SHFM1): additional support for functional haploinsufficiency as the causative mechanism. Eur J Hum Genet 2009; 17 (11) 1432-1438
    Google Scholar
  • 7 Rai A, Srivastava P, Phadke SR. Deletion 7q21.2-q22.1 in a case with split hand-split foot malformation, sensorineural hearing loss and intellectual disability: phenotype subtypes and the correlation with genotypes. Eur J Med Genet 2019; 62 (12) 103597
    Google Scholar
  • 8 Saugier-Veber P, Doummar D, Barthez MA. et al. Myoclonus dystonia plus syndrome due to a novel 7q21 microdeletion. Am J Med Genet A 2010; 152A (05) 1244-1249
    Google Scholar
  • 9 Obenauf AC, Schwarzbraun T, Auer M. et al. Mapping of balanced chromosome translocation breakpoints to the basepair level from microdissected chromosomes. J Cell Mol Med 2010; 14 (08) 2078-2084
    Google Scholar
  • 10 Dale RC, Nasti JJ, Peters GB. Familial 7q21.3 microdeletion involving epsilon-sarcoglycan causing myoclonus dystonia, cognitive impairment, and psychosis. Mov Disord 2011; 26 (09) 1774-1775
    Google Scholar
  • 11 Vera-Carbonell A, Moya-Quiles MR, Ballesta-Martínez M. et al. Rapp-Hodgkin syndrome and SHFM1 patients: delineating the p63-Dlx5/Dlx6 pathway. Gene 2012; 497 (02) 292-297
    Google Scholar
  • 12 Kim K-B, Ha J-S, Shin S-J, Kim CS, Bae J-G. Prenatal diagnosis of a 7q21.13q22.1 deletion detected using high-resolution microarray. Obstet Gynecol Sci 2014; 57 (04) 318-324
    Google Scholar
  • 13 Delgado S, Velinov M. 7q21.3 Deletion involving enhancer sequences within the gene DYNC1I1 presents with intellectual disability and split hand-split foot malformation with decreased penetrance. Mol Cytogenet 2015; 8 (01) 37
    Google Scholar
  • 14 Sivasankaran A, Srikanth A, Kulshreshtha PS, Anuradha D, Kadandale JS, Samuel CR. Split hand/foot malformation associated with 7q21.3 microdeletion: a case report. Mol Syndromol 2016; 6 (06) 287-296
    Google Scholar
  • 15 Ramos-Zaldívar HM, Martínez-Irías DG, Espinoza-Moreno NA. et al. A novel description of a syndrome consisting of 7q21.3 deletion including DYNC1I1 with preserved DLX5/6 without ectrodactyly: a case report. J Med Case Reports 2016; 10 (01) 156
    Google Scholar
  • 16 Crackower MA, Scherer SW, Rommens JM. et al. Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development. Hum Mol Genet 1996; 5 (05) 571-579
    Google Scholar
  • 17 Saunders Jr JW. Is the progress zone model a victim of progress?. Cell 2002; 110 (05) 541-543
    Google Scholar
  • 18 Duijf PHG, van Bokhoven H, Brunner HG. Pathogenesis of split-hand/split-foot malformation. Hum Mol Genet 2003; 12 (Spec No 1): R51-R60
    Google Scholar
  • 19 Kouwenhoven EN, van Heeringen SJ, Tena JJ. et al. Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. PLoS Genet 2010; 6 (08) e1001065
    Google Scholar
  • 20 Gennerich A, Carter AP, Reck-Peterson SL, Vale RD. Force-induced bidirectional stepping of cytoplasmic dynein. Cell 2007; 131 (05) 952-965
    Google Scholar
  • 21 Birnbaum RY, Clowney EJ, Agamy O. et al. Coding exons function as tissue-specific enhancers of nearby genes. Genome Res 2012; 22 (06) 1059-1068
    Google Scholar
  • 22 Hong JW, Hendrix DA, Levine MS. Shadow enhancers as a source of evolutionary novelty. Science 2008; 321 (5894): 1314
    Google Scholar
  • 23 van Dijk FS, Huizer M, Kariminejad A. et al. Complete COL1A1 allele deletions in osteogenesis imperfecta. Genet Med 2010; 12 (11) 736-741
    Google Scholar
  • 24 Makareeva E, Mertz EL, Kuznetsova NV. et al. Structural heterogeneity of type I collagen triple helix and its role in osteogenesis imperfecta. J Biol Chem 2008; 283 (08) 4787-4798
    Google Scholar
  • 25 Rauch F, Lalic L, Roughley P, Glorieux FH. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J Bone Miner Res 2010; 25 (06) 1367-1374
    Google Scholar
  • 26 Grabowski M, Zimprich A, Lorenz-Depiereux B. et al. The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur J Hum Genet 2003; 11 (02) 138-144
    Google Scholar
  • 27 Esapa CT, Waite A, Locke M. et al. SGCE missense mutations that cause myoclonus-dystonia syndrome impair ε-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA. Hum Mol Genet 2007; 16 (03) 327-342
    Google Scholar
  • 28 Müller B, Hedrich K, Kock N. et al. Evidence that paternal expression of the ε-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 2002; 71 (06) 1303-1311
    Google Scholar
  • 29 Etich J, Leßmeier L, Rehberg M. et al. Osteogenesis imperfecta-pathophysiology and therapeutic options. Mol Cell Pediatr 2020; 7 (01) 9
    Google Scholar
  • 30 Haberlandt E, Löffler J, Hirst-Stadlmann A. et al. Split hand/split foot malformation associated with sensorineural deafness, inner and middle ear malformation, hypodontia, congenital vertical talus, and deletion of eight microsatellite markers in 7q21.1-q21.3. J Med Genet 2001; 38 (06) 405-409
    Google Scholar
  • 31 Courtens W, Vermeulen S, Wuyts W. et al. An interstitial deletion of chromosome 7 at band q21: a case report and review. Am J Med Genet A 2005; 134A (01) 12-23
    Google Scholar
  • 32 Aswini S, Ambika S, Pooja K, Anuradha D, Kadandale J, Samuel C. Split hand/foot malformation type 1 associated with 7q21.3 deletion—a case report. Mol Cytogenet 2014; 7: 57
    Google Scholar
  • 33 Babameto-Laku A, Roko D, Vyshka G. Genetic diagnosis of chromosomal congenital anomalies in Albanian pediatric patients by array CGH. Open Access Maced J Med Sci 2017; 5 (05) 587-591
    Google Scholar
  • 34 Fukushima K, Nagai K, Tsukada H. et al. Deletion mapping of split hand/split foot malformation with hearing impairment: a case report. Int J Pediatr Otorhinolaryngol 2003; 67 (10) 1127-1132
    Google Scholar
  • 35 Yan WL, Guan XY, Green ED. et al. Childhood-onset schizophrenia/autistic disorder and t(1;7) reciprocal translocation: identification of a BAC contig spanning the translocation breakpoint at 7q21. Am J Med Genet 2000; 96 (06) 749-753
    Google Scholar
  • 36 Tzschach A, Menzel C, Erdogan F. et al. Characterization of a 16 Mb interstitial chromosome 7q21 deletion by tiling path array CGH. Am J Med Genet A 2007; 143 (04) 333-337
    Google Scholar
  • 37 Tackels-Horne D, Toburen A, Sangiorgi E. et al. Split hand/split foot malformation with hearing loss: first report of families linked to the SHFM1 locus in 7q21. Clin Genet 2001; 59 (01) 28-36
    Google Scholar
  • 38 Bernardini L, Palka C, Ceccarini C. et al. Complex rearrangement of chromosomes 7q21.13-q22.1 confirms the ectrodactyly-deafness locus and suggests new candidate genes. Am J Med Genet A 2008; 146A (02) 238-244
    Google Scholar
  • 39 Bonnet C, Grégoire MJ, Vibert M, Raffo E, Leheup B, Jonveaux P. Cryptic 7q21 and 9p23 deletions in a patient with apparently balanced de novo reciprocal translocation t(7;9)(q21;p23) associated with a dystonia-plus syndrome: paternal deletion of the epsilon-sarcoglycan (SGCE) gene. J Hum Genet 2008; 53 (10) 876-885
    Google Scholar
  • 40 Saitsu H, Kurosawa K, Kawara H. et al. Characterization of the complex 7q21.3 rearrangement in a patient with bilateral split-foot malformation and hearing loss. Am J Med Genet A 2009; 149A (06) 1224-1230
    Google Scholar
  • 41 Brown KK, Reiss JA, Crow K. et al. Deletion of an enhancer near DLX5 and DLX6 in a family with hearing loss, craniofacial defects, and an inv(7)(q21.3q35). Hum Genet 2010; 127 (01) 19-31
    Google Scholar
  • 42 McElveen C, Carvajal MV, Moscatello D, Towner J, Lacassie Y. Ectrodactyly and proximal/intermediate interstitial deletion 7q. Am J Med Genet 1995; 56 (01) 1-5
    Google Scholar
  • 43 Katarzyna MM, Jarosław S, Katarzyna JP, Wojciech S, Magdalena F. Recurrent Streptococcus pneumoniae meningitis in a child with split hand and foot malformation and undiagnosed mondini dysplasia. J Dev Phys Disabil 2015; 27 (06) 823-829
    Google Scholar
  • 44 Rattanasopha S, Tongkobpetch S, Srichomthong C, Kitidumrongsook P, Suphapeetiporn K, Shotelersuk V. Absent expression of the osteoblast-specific maternally imprinted genes, DLX5 and DLX6, causes split hand/split foot malformation type I. J Med Genet 2014; 51 (12) 817-823
    Google Scholar
  • 45 Lango Allen H, Caswell R, Xie W. et al. Next generation sequencing of chromosomal rearrangements in patients with split-hand/split-foot malformation provides evidence for DYNC1I1 exonic enhancers of DLX5/6 expression in humans. J Med Genet 2014; 51 (04) 264-267
    Google Scholar
  • 46 Li C, Lyu Y, Hou R, Liu C, Li-Ling J, Li H. Clinical feature and pathogenic analysis of a fetus with split hand-foot malformation. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2020; 37 (04) 462-466
    Google Scholar
  • 47 Johnson KR, Gagnon LH, Tian C. et al. Deletion of a long-range Dlx5 enhancer disrupts inner ear development in mice. Genetics 2018; 208 (03) 1165-1179
    Google Scholar
  • 48 Wieland I, Muschke P, Jakubiczka S, Volleth M, Freigang B, Wieacker PF. Refinement of the deletion in 7q21.3 associated with split hand/foot malformation type 1 and Mondini dysplasia. J Med Genet 2004; 41 (05) e54
    Google Scholar
  • 49 DeBerardinis RJ, Conforto D, Russell K. et al. Myoclonus in a patient with a deletion of the epsilon-sarcoglycan locus on chromosome 7q21. Am J Med Genet A 2003; 121A (01) 31-36
    Google Scholar
  • 50 Grünewald A, Djarmati A, Lohmann-Hedrich K. et al. Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat 2008; 29 (02) 331-332
    Google Scholar
  • 51 Peall KJ, Kurian MA, Wardle M. et al. SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype. J Neurol 2014; 261 (12) 2296-2304
    Google Scholar
  • 52 Misbahuddin A, Placzek M, Lennox G, Taanman JW, Warner TT. Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the ε-sarcoglycan gene. Mov Disord 2007; 22 (08) 1173-1175
    Google Scholar
  • 53 Zimprich A, Grabowski M, Asmus F. et al. Mutations in the gene encoding ε-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 2001; 29 (01) 66-69
    Google Scholar
  • 54 Foncke EMJ, Gerrits MCF, van Ruissen F. et al. Distal myoclonus and late onset in a large Dutch family with myoclonus-dystonia. Neurology 2006; 67 (09) 1677-1680
    Google Scholar
  • 55 Dauwerse JG, Ruivenkamp CA, Hansson K. et al. A complex chromosome 7q rearrangement identified in a patient with mental retardation, anxiety disorder, and autistic features. Am J Med Genet A 2010; 152A (02) 427-433
    Google Scholar
  • 56 Mannstadt M, Lin AE, Le LP. Case records of the Massachusetts General Hospital. Case 24-2014. A 27-year-old man with severe osteoporosis and multiple bone fractures. N Engl J Med 2014; 371 (05) 465-472
    Google Scholar
  • 57 Bardai G, Lemyre E, Moffatt P. et al. Osteogenesis imperfecta type I caused by COL1A1 deletions. Calcif Tissue Int 2016; 98 (01) 76-84
    Google Scholar
  • 58 Cohen-Solal L, Zolezzi F, Pignatti PF, Mottes M. Intrafamilial variable expressivity of osteogenesis imperfecta due to mosaicism for a lethal G382R substitution in the COL1A1 gene. Mol Cell Probes 1996; 10 (03) 219-225
    Google Scholar
  • 59 Nuytinck L, Sayli BS, Karen W, De Paepe A. Prenatal diagnosis of osteogenesis imperfecta type I by COL1A1 null-allele testing. Prenat Diagn 1999; 19 (09) 873-875
    Google Scholar